🔎 Trials Near Me

홈 › 신장암 (신세포암) › 메릴랜드

메릴랜드의 신장암 (신세포암) 임상 시험

신장암 (신세포암) 관련 연구 17개가 메릴랜드 내 여러 지역에서 참여자를 모집하고 있습니다.

메릴랜드의 도시

공식 연구 텍스트(영어)

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

  • Research Site, Baltimore
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05536141

Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

  • National Institutes of Health Clinical Center, Bethesda
피험자 모집 중2상
18세 ~ 120세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05155033

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Medical Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
  • 외 10개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #14, Baltimore
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • National Institutes of Health Clinical Center, Bethesda
  • FMH James M Stockman Cancer Institute, Frederick
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT03866382

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

  • NCI - Center for Cancer Research, Bethesda
피험자 모집 중2상
12세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT04981509

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

  • Johns Hopkins Hospital, Baltimore
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07293351

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • UPMC Western Maryland, Cumberland
  • UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06661720

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

  • National Institutes of Health Clinical Center, Bethesda
피험자 모집 중관찰 연구건강한 지원자 환영
2세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT00001238

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

  • National Institutes of Health Clinical Center, Bethesda
피험자 모집 중1/2상
18세 ~ 72세 · 모든 성별 · 2026. 8. 13. 업데이트됨 · NCT02830724

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

  • National Institutes of Health Clinical Center, Bethesda
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT04923178

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

  • Greater Baltimore Medical Center ( Site 0145), Baltimore
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT07227402

Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

  • National Institutes of Health Clinical Center, Bethesda
피험자 모집 중1/2상
18세 ~ 100세 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT05665361

Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell

  • Johns Hopkins University, Baltimore
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 21. 업데이트됨 · NCT07062549

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

  • Johns Hopkins University (Data Collection Only), Baltimore
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 24. 업데이트됨 · NCT06835972

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

  • Johns Hopkins Hospital /ID# 254056, Baltimore
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT04777994

Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations

  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
피험자 모집 중2상
18세 ~ 120세 · 모든 성별 · 2026. 3. 30. 업데이트됨 · NCT03786796

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.